Employer-Sponsored Pharmacist Diabetes Program Improves Outcomes

SHORT-TERM OUTCOMES FOR AN EMPLOYER SPONSORED PHARMACIST-PROVIDED MULTI CENTER DIABETES MANAGEMENT PROGRAM Sharrel L. Pinto, B.S Pharm, Ph.D, Assistant Professor and Director 1 , Jinender Kumar, B. Pharm, PGDBM, Research Assistant 2 1,2 The Pharmaceutical Care and Outcomes Research Laboratory, Department of Pharmacy Health Care Administration, College of Pharmacy, University of Toledo, Ohio, USA Introduction Objective Methods Results Discussion and Study Implications References Results Cont….. Clinical, Social and Process Measures Humanistic Outcomes Economic Outcomes Table 2: Quality of life (Using SF – 36 v.2) Table 3: Disease-Specific Knowledge Surveys Table 4: Patient Satisfaction and Self-Reported Patient Adherence Conclusion Table1 : Changes in Clinical, Social, And Process Measures Table 5: Economic Outcomes PDB53 Goal Methods Cont….. Medication Therapy Management (MTM) programs are an innovative approach to optimize patient health outcomes for ongoing disease states through integrative care. 1 In last few years, there is a strong emphasis for employer sponsored MTM programs to develop across the country. These programs encourage employees to take advantage of MTM programs at the cost of their employer. Previous work in this area has demonstrated a positive impact of pharmacists’ interventions but has lacked the foundation of a conceptually coherent framework to track outcomes. 2-4 This study has utilized a theoretical framework to examine effects of pharmacists’ interventions on patient health outcomes using economic, clinical, and humanistic outcomes (ECHO) model. To measure the impact of a pharmacist-provided MTMP on the economic, clinical, and humanistic outcomes for the City of Toledo employees and their dependents for a period of six months ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1. Bennett M, Bertram C, Chater R, et al. Medication Therapy Management in Community Pharmacy Practice: Core Elements of an MTM Service Version 1.0. April 25, 2005. 2. Cranor C.W., Bunting B.A., Christensen D.B. The Asheville Project:Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc.2003;43:173-84. 3. Fera T, Bluml B.M. et a., The Diabetes Ten City Challenge: Interim clinicaland humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc.2008;48:181-190. 4. Garrett D.G, Bluml B.M, Patient Self-Management Program for Diabetes : First-Year Clinical, Humanistic, and Economic Outcomes. J Am Pharm Assoc.2005;45:130-137 5. Larson, LN, Rovers, JP, MacKeigan, LD. Patient satisfaction with pharmaceutical care: update of a validated instrument. J Am Pharm Assoc. 2002; 42(1): 44-50. 6. Doucette, WR, McDonough, RP. Beyond the 4Ps: using relationship marketing to build value and demand for pharmacy services. J Am Pharm Assoc. 2002; 42: 183-93. 7. Hooker, RS, Potts, R, Ray, W. Patient satisfaction: comparing physician assistants, nurse practitioners, and physicians. The Permanente Journal. 1997; 1(1): 38-42. 8. Ragucci K.R., Fermo J.D. et al. Effectiveness of pharmacist-adminstered diabetes mellitus education and management services. Pharmacotherapy. 2005;25(12):1809-1816. 9. Wagner e, Sandhu N, Newton K et al. Effect of improved glycemic control on health care cost ad utilization. JAMA.2001;285:182-9. 10. Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006; 26(1):68-79. 11. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc. 2002; 42(1):36-43. 12. Ried LD, Wang F, Young H, Awiphan R. Patients' satisfaction and their perception of the pharmacist. J Am Pharm Assoc. 1999; 39(6):835-842. 13. Lau, C., Qureshi, A., & Scott, S. (2004). Association between glycaemic control and quality of life in diabetes mellitus. Journal of Postgraduate Medicine, 50(3), 189-93; discussion 194. 14. Hill-Briggs, F., Gary, T., Baptiste-Roberts, K., & Brancati, F. (2005). Thirty-six-item short-form outcomes following a randomized controlled trial in type 2 diabetes. Diabetes Care , 28 (2), 443-4. 15. Mayer B. Davidson, MD SF-36 and Diabetes Outcome Measures Diabetes Care 28:1536-1537, 2005 16. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs J Behav Med. 2009 Jan 30. Epub ahead of print. 17. Viviam E.M., Improving Blood Pressure Control in a Pharmacists-Managed Hypertension Clinic. Pharmacotherapy.2002;22(12):1553-1540 . Available Data: 92 Patients Available data: Baseline - 98 Patients 3 Months – 73 Patients 6 Months – 50 Patients The six month evaluation of the pharmacist-provided MTM program for diabetes has shown to be successful in improving clinical, humanistic, and economic outcomes of City of Toledo employees and their dependents. # - Friedman Test for Paired Data (significance at α = 0.05) * - Wilcoxon Signed Rank Test for Paired Data (Baseline to 3 months) (significance at α = 0.05) The mean norm based score for US general population with diabetes are 41.10 ± 11.16 for Physical component Summary and 47.75 ± 11.49 for Mental Component Summary. A higher score at follow up visit indicates improved quality of life. Each domain have separate minimum and maximum scores. The details about the meaning of each domain scores can be found in the User Manual for SF-36 v2 Survey by Quality Metrics. Knowledge tests are scored on a scale of 1-10 (1 – Low Knowledge, 10 – High Knowledge) Patient satisfaction and patient adherence are scored on a scale of 1-5. The higher the score, the more improved was the satisfaction or adherence. Funding: This study was funded by a seed grant from The National Business Coalition on Health Acknowledgements: City of Toledo, FrontPath Health Coalition, Toledo Area Network of Independent Pharmacies To measure the short term outcomes of an employer sponsored pharmacists- provided MTM program in a community pharmacy setting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Presented at the ISPOR 14th Annual International Meeting, Orlando, Florida, May 16-20, 2009

Employer-Sponsored Pharmacist Diabetes Program Improves Outcomes

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (7)

Similar a Employer-Sponsored Pharmacist Diabetes Program Improves Outcomes

Similar a Employer-Sponsored Pharmacist Diabetes Program Improves Outcomes (20)

Último

Último (20)

Employer-Sponsored Pharmacist Diabetes Program Improves Outcomes